• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低剂量重组活化凝血因子 VII 暂时止住严重产后出血时的小动脉出血:一例报告

Low-dose recombinant activated factor VII temporally stopped bleeding from small artery in severe postpartum hemorrhage: a case report.

作者信息

Ogawa Masaki, Akahira Saeko, Takahashi Satoshi, Shimoda Yuki, Sato Megumi, Sato Akira, Terada Yukihiro

机构信息

Perinatal Care Center, Department of Obstetrics and Gynecology, Akita University Hospital, Hondo, Akita, Japan.

出版信息

Blood Coagul Fibrinolysis. 2013 Apr;24(3):344-6. doi: 10.1097/MBC.0b013e32835975b1.

DOI:10.1097/MBC.0b013e32835975b1
PMID:23448730
Abstract

Recombinant activated factor VII has been used to effectively treat uncontrolled massive hemorrhage at parturition in an off-label manner. Interventional radiology, including vessel embolization of the internal iliac artery or uterine artery for postpartum hemorrhage, is now familiar to obstetricians. However, this therapeutic technique is applicable only in patients who are hemodynamically stable. We encountered a case with severe and uncontrolled postpartum bleeding from the vaginal fornix. The patient received a low dose (<20 μg/kg) of factor VIIa and subsequently underwent vessel embolization. We herein report that this stepwise treatment was very effective for uncontrolled bleeding.

摘要

重组活化因子VII已被用于以超适应症方式有效治疗分娩时无法控制的大量出血。介入放射学,包括髂内动脉或子宫动脉血管栓塞术治疗产后出血,现在产科医生已熟知。然而,这种治疗技术仅适用于血流动力学稳定的患者。我们遇到一例阴道穹窿严重且无法控制的产后出血病例。该患者接受了低剂量(<20μg/kg)的VIIa因子治疗,随后进行了血管栓塞术。我们在此报告,这种分步治疗对无法控制的出血非常有效。

相似文献

1
Low-dose recombinant activated factor VII temporally stopped bleeding from small artery in severe postpartum hemorrhage: a case report.低剂量重组活化凝血因子 VII 暂时止住严重产后出血时的小动脉出血:一例报告
Blood Coagul Fibrinolysis. 2013 Apr;24(3):344-6. doi: 10.1097/MBC.0b013e32835975b1.
2
Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.重组活化因子VII(rFVIIa)控制难治性产后出血的有效性:两例报告及文献综述
J Med Assoc Thai. 2007 May;90(5):977-81.
3
Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.重组活化凝血因子VII在一例严重产后出血中的应用。
Minerva Ginecol. 2006 Feb;58(1):81-4.
4
Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta.使用重组活化凝血因子 VII、B-Lynch 压迫法及子宫动脉可逆性栓塞术治疗严重保守治疗无效的产后出血:胎盘植入病例大出血管理的新方法
Fertil Steril. 2008 Nov;90(5):2012.e1-5. doi: 10.1016/j.fertnstert.2007.12.057. Epub 2008 May 7.
5
[Post-partum hemorrhage: new therapeutic options].[产后出血:新的治疗选择]
Recenti Prog Med. 2007 Jan;98(1):7-11.
6
[Case Report: Recurrent postpartum haemorrhage after emergency caesarean section - Clipping, embolization and haemostaseological therapy].[病例报告:急诊剖宫产术后复发性产后出血——夹闭、栓塞及止血治疗]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2012 May;47(5):308-14. doi: 10.1055/s-0032-1313568. Epub 2012 May 24.
7
Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
Acta Obstet Gynecol Scand. 2006;85(10):1239-47. doi: 10.1080/00016340600855839.
8
A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.关于重组凝血因子VIIa在危及生命的产科产后出血中应用的批判性综述。
Semin Thromb Hemost. 2008 Feb;34(1):104-12. doi: 10.1055/s-2008-1066022.
9
Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).重组活化因子 VII(rFVIIa)治疗产科出血
Arch Gynecol Obstet. 2003 Oct;268(4):266-7. doi: 10.1007/s00404-002-0409-1. Epub 2002 Nov 7.
10
[Recombinant factor VII-a--new possibility for the treatment of severe postpartal bleeding--literature review].
Akush Ginekol (Sofiia). 2004;43(5):44-6.

引用本文的文献

1
Use of Recombinant Activated Factor VII: Pakistani Experience of Managing Massive Obstetric Haemorrhage.重组活化凝血因子 VII 的应用:巴基斯坦处理产科大出血的经验
Niger Med J. 2022 May 13;62(5):267-272. doi: 10.60787/NMJ-62-5-53. eCollection 2021 Sep-Oct.
2
Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage.重组活化凝血因子VII作为产后出血的二线治疗方法。
Korean J Crit Care Med. 2017 Nov;32(4):333-339. doi: 10.4266/kjccm.2016.00787. Epub 2017 Nov 30.